the partners
news
-
2019/10/04
We are delighted to report that the Centre Hospitalier Universitaire Gabriel Touré in Mali (in liaison with Anne-Genevieve Marcelin, France) […]
read more -
2019/07/12
With issue of the 2nd EPIICAL newsletter, we are pleased to announce that a poster on the CARMA study has been accepted for a presentation at both the 10th International AIDS Society 2019 Conference on HIV Science and pre-meeting: ‘2019 HIV & HBV Cure Forum’.
read more -
2019/05/13
With the EPIICAL project being a hive of activity over the last year, we have collected a selection of contributions, stories and articles to bring you the very first edition of the EPIICAL newsletter!
read more
publications
-
Human Immunodeficiency Virus (HIV) – Antibody Repertoire Estimates Reservoir Size and Time of Antiretroviral Therapy Initiation in Virally Suppressed Perinatally HIV-Infected Children
2018/09/04Background. Assays to estimate human immunodeficiency virus (HIV) reservoir size require large amounts of blood, which represents a drawback especially […]
read more -
Early and Highly Suppressive ART are Main Factors Associated with Low Viral Reservoir in European Perinatally HIV Infected Children
2018/06/26Future strategies aiming to achieve HIV-1 remission are likely to target individuals with small reservoir size. We retrospectively investigated factors associated with HIV-1 DNA levels in European, perinatally HIV-infected children starting ART <6 months of age.
read more -
The EPIICAL Project: an Emerging Global Collaboration to Investigate Immunotherapeutic Strategies in HIV-Infected Children
2016/02/16The EPIICAL (Early-treated Perinatally HIV-infected Individuals: Improving Children’s Actual Life with Novel Immunotherapeutic Strategies) project arises from the firm belief […]
read more